GK
Gopinath Krishnappa
National Institute of Mental Health and Neurosciences, Chromous Biotech (P) Ltd, Abexome Bioscience (P) Ltd
Research areas: Biochemistry, Genetics and Molecular Biology · Molecular Biology · Genomics, phytochemicals, and oxidative stress · Enzyme Structure and Function · Parkinson's Disease Mechanisms and Treatments
0000-0002-3504-8296
About
Structural biology, molecular biology, Protein chemistry, chromatography & biophysical techniques, cell biology & immunology.
Employment
-
National institute of mental health and neurosciences Senior researcher2019 - 2022
-
National Institute of Mental Health and Neurosciences Senior researcher2015 - 2018
-
Chromous Biotech (P) Ltd Team lead2013 - 2015
-
Abexome Bioscience (P) Ltd Assistant Scientist2011 - 2013
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (6)
- Structural Basis for the Essential Role of Ca2+ in the Lytic Activity of Staphylococcus aureus PlyGRCS Endolysin Targeting Methicillin-Resistant Staphylococcus aureus. Save
- Structural and biochemical insights into the bacteriophage PlyGRCS endolysin targeting methicillin‐resistant Staphylococcus aureus (MRSA) and serendipitous discovery of its interaction with a cold shock protein C (CspC) Save
- Chlorhexidine as a Keap1-Nrf2 inhibitor: a new target for an old drug for Parkinson's disease therapy. Save
- Structural insights into the multiple binding modes of Dimethyl Fumarate (DMF) and its analogs to the Kelch domain of Keap1. Save
- Novel pyrano 1,3 oxazine based ligand inhibits the epigenetic reader hBRD2 in glioblastoma. Save
- The Keap1-Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases. Save